De Martino MC - Search Results

1

The role of mTOR pathway as target for treatment in adrenocortical cancer.

De Martino MC, Feelders RA, Pivonello C, Simeoli C, Papa F, Colao A, Pivonello R, Hofland LJ. De Martino MC, et al. Endocr Connect. 2019 Sep;8(9):R144-R156. doi: 10.1530/EC-19-0224. Endocr Connect. 2019. PMID: 31398711 Free PMC article. Review.

2

[New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].

Colao A, Pulcrano M, Dorato M, Müller F, Rossi FW, De Martino MC, Biondi B, Lombardi G. Colao A, et al. Among authors: de martino mc. Minerva Endocrinol. 2001 Dec;26(4):231-8. Minerva Endocrinol. 2001. PMID: 11782708 Review. Italian.

3

Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration.

Pivonello R, Faggiano A, Filippella M, Di Somma C, De Martino MC, Gaccione M, Lombardi G, Colao A. Pivonello R, et al. Among authors: de martino mc. J Endocrinol Invest. 2002 Dec;25(11):932-7. doi: 10.1007/BF03344064. J Endocrinol Invest. 2002. PMID: 12553551

4

Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission.

Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A. Faggiano A, et al. Among authors: de martino mc. J Clin Endocrinol Metab. 2003 Jun;88(6):2527-33. doi: 10.1210/jc.2002-021558. J Clin Endocrinol Metab. 2003. PMID: 12788849

5

An evaluation of patients with hyperprolactinemia: have dynamic tests had their day?

Di Sarno A, Rota F, Auriemma R, De Martino MC, Lombardi G, Colao A. Di Sarno A, et al. Among authors: de martino mc. J Endocrinol Invest. 2003;26(7 Suppl):39-47. J Endocrinol Invest. 2003. PMID: 14604065 Review.

6

The role of somatostatin receptors in the medical treatment of acromegaly.

Vitale G, Pivonello R, Ferone D, De Martino MC, Auriemma RS, Caraglia M, Abbruzzese A, Lombardi G, Colao A. Vitale G, et al. Among authors: de martino mc. Dig Liver Dis. 2004 Feb;36 Suppl 1:S55-9. doi: 10.1016/j.dld.2003.11.022. Dig Liver Dis. 2004. PMID: 15077912 Review.

7

Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors.

Pivonello R, Ferone D, Filippella M, Faggiano A, De Martino MC, Auriemma RS, Rota F, Lombardi G, Colao A. Pivonello R, et al. Among authors: de martino mc. J Endocrinol Invest. 2003;26(8 Suppl):82-8. J Endocrinol Invest. 2003. PMID: 15233220 Review. No abstract available.

8

The use of a GH receptor antagonist in patients with acromegaly resistant to somatostatin analogs.

Colao A, Pivonello R, Cappabianca P, Auriemma RS, De Martino MC, Ciccarelli A, de Divitiis E, Lombardi G. Colao A, et al. Among authors: de martino mc, de divitiis e. J Endocrinol Invest. 2003;26(10 Suppl):53-6. J Endocrinol Invest. 2003. PMID: 15497660 Review.

9

Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.

Colao A, Spiezia S, Di Somma C, Pivonello R, Marzullo P, Rota F, Musella T, Auriemma RS, De Martino MC, Lombardi G. Colao A, et al. Among authors: de martino mc. J Endocrinol Invest. 2005 May;28(5):440-8. doi: 10.1007/BF03347225. J Endocrinol Invest. 2005. PMID: 16075928

10

Severe systemic complications of acromegaly.

Colao A, Pivonello R, Marzullo P, Auriemma RS, De Martino MC, Ferone D, Lombardi G. Colao A, et al. Among authors: de martino mc. J Endocrinol Invest. 2005;28(5 Suppl):65-77. J Endocrinol Invest. 2005. PMID: 16114280 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page